August 26th 2025
Read the full, exclusive transcript from the inaugural "Brain Trust: Conversations in Clinical Psychopharmacology" video with Joseph F. Goldberg, MD, and Marlene Freeman, MD.
Key Concepts About Polypharmacy in Psychotic Disorders
August 3rd 2020Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.
Read More
Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings
February 28th 2020Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.
Read More
Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
January 30th 2020Although multiple interventions exist for major depressive disorder (MDD), only partial response is achieved in many patients and recurrence is common. Combining medication and psychotherapy may enable more effective treatment of MDD.
Read More
When Medications Affect More Than the Patient: Opioids and Family Members
December 30th 2019Three studies highlight how important it is that when physicians prescribe opioids there can be significant and even potentially fatal consequences for the family members of those for whom they are being prescribed.
Read More
Psychiatric Adverse Effects of Antibiotics
Nearly all antibiotic agents have been associated with CNS effects. Although uncommon, these events can be severe.
Read More